Rapid Dose Therapeutics Corp's market cap is currently ―. The company's EPS TTM is C$-0.046; its P/E ratio is ―; Rapid Dose Therapeutics Corp is scheduled to report earnings on February 3, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.

	Aug 24	May 24	Feb 24	Nov 23	Aug 23
Income Statement	-
Total Revenue	$ 515.92K	$ 398.99K	$ 192.65K	$ 233.81K	$ 353.17K
Gross Profit	$ 328.00K	$ 256.70K	$ 72.46K	$ 129.40K	$ 243.94K
EBIT	$ -857.51K	$ -954.25K	$ -1.74M	$ -878.49K	$ -556.40K
EBITDA	$ -807.30K	$ -871.52K	$ -1.56M	$ -725.65K	$ -416.21K
Net Income Common Stockholders	$ -1.10M	$ -1.26M	$ -2.03M	$ -981.08K	$ -730.68K
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 71.68K	$ 113.06K	$ 161.06K	$ 166.18K	$ 203.43K
Total Assets	$ 1.72M	$ 1.81M	$ 1.89M	$ 1.99M	$ 2.10M
Total Debt	$ ―	$ ―	$ ―	$ 2.70M	$ 2.46M
Net Debt	$ ―	$ ―	$ ―	$ 2.53M	$ 2.26M
Total Liabilities	$ 5.47M	$ 5.12M	$ 5.04M	$ 6.53M	$ 5.94M
Stockholders Equity	$ -3.76M	$ -3.31M	$ -3.16M	$ -4.54M	$ -3.84M
Cash Flow	-
Free Cash Flow	$ -261.31K	$ -622.31K	$ -1.31M	-	-
Operating Cash Flow	$ -261.31K	$ -622.31K	$ -1.31M	$ -672.67K	$ -183.23K
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	$ 219.93K	$ 574.32K	$ 1.30M	$ 635.42K	$ 353.84K

Currency in USD

Rapid Dose Therapeutics Corp Earnings and Revenue History

Income Statement >

Rapid Dose Therapeutics Corp Debt to Assets

Balance Sheet >

Rapid Dose Therapeutics Corp Cash Flow

Cash Flow >

Rapid Dose Therapeutics Corp Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing